Table VI.

Cannabinoid receptor 2 (CNR2) gene and osteoporosis (OP) risk association measured by haplotype analysis

Haplotype (rs3003336-rs2501431)	Frequency (ratio)		OR (95% CI)	p-value*
	OP patient	Control
A-T	0.4922	0.5287	1.00	N/A
G-T	0.2386	0.2191	1.10 (0.76 to 1.67)	0.512
A-C	0.2068	0.218	1.23 (0.83 to 1.74)	0.421
G-C	0.0624	0.0342	1.54 (1.19 to 1.96)	< 0.001†

^*Adjusted for sex, age, smoking status, and body mass index

^†Statistically significant

OR, odds ratio; CI, confidence interval; N/A, not applicable